Airway Therapeutics, Inc., 2026-09-09
A new SEC Form D private-offering notice from Marietta, GA, a $50,584,517 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biopharmaceutical company developing zelpultide alfa, a recombinant surfactant protein D therapy for bronchopulmonary dysplasia and other respiratory and inflammatory diseases
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Monteforte Group, LLC, 2026-09-09, $1.5M, Canton, GA
- Cloverleaf Bio, Inc., 2026-09-09, $29.6M, New Haven, CT
- ASW Holdings, LLC, 2026-09-04, $7.2M, Atlanta, GA
- Iambic Therapeutics, Inc., 2026-09-09, $66.5M, San Diego, CA
- LifeCyte Innovations, Inc., 2026-08-20, $5M, Greensboro, GA
- Animal Biosciences, Inc., 2026-09-09, $2.6M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.